Sales reps& bias lawsuit against Novartis to move forward

Share this article:

A US judge has ruled that Novartis Pharmaceuticals will have to defend itself against sex-discrimination claims brought by a group of female sales employees in a $100 million class-action lawsuit.

Judge Gerald Lynch granted class-action status to a lawsuit in US District Court in Manhattan against Novartis by 19 current and former sales employees, according to published reports.

In his order, the judge also granted a request to dismiss claims against Novartis Corp., the pharmaceutical unit's parent.

The lawsuit, filed in 2004, alleged Novartis' pharma unit was discriminatory in its pay, promotions, evaluations and treatment of women who take pregnancy leave.

A Novartis spokesman said the company's lawyers just received the documents related to the lawsuit and were reviewing them.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.